| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $4.58T | $4.26T | $4.03T | $3.57T | $3.20T |
| Cost of Revenue | $1.58T | $1.43T | $1.24T | $1.11T | $994.31B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $730.23B | $729.92B | $633.33B | $526.09B | $455.83B |
| SG&A | $1.10T | $1.05T | $997.31B | $886.36B | $875.66B |
| Operating Income | $342.59B | $214.07B | $490.50B | $460.84B | $509.27B |
| Interest Expense | $210.06B | $219.85B | $169.70B | $166.61B | $248.63B |
| Tax Expense | $66.94B | -$91.41B | $58.05B | $72.41B | -$9.94B |
| Net Income | $108.14B | $144.20B | $317.04B | $230.17B | $376.17B |
| EPS (basic) | 68.3600 | 92.0900 | 204.2900 | 147.1400 | 240.7200 |
| EPS (diluted) | 67.2300 | 91.1600 | 201.9400 | 145.8700 | 238.9600 |
| Shares (diluted) | $1.61B | $1.58B | $1.57B | $1.58B | $1.57B |